Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00891956 · ClinicalTrials.gov registry record

The Role of Family Functioning in Adaptation to Being a Caregiver of an Individual With Rett Syndrome

A clinical trial of Rett Syndrome, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
426
Enrollment target
3
Study locations

NCT00891956: Completed study of Rett Syndrome, sponsored by National Human Genome Research Institute (NHGRI).

NCT00891956 is a study of Rett Syndrome that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 426 participants, below the 502-participant average among 18 other Rett Syndrome trials with a reported enrollment target (15% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00891956, a study of Rett Syndrome, has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
426 participants
Enrollment target
3
Study locations

Study Summary

Background: * Rett syndrome (RS) is a panethnic (affecting all ethnicities) neurodevelopmental (impairment of the growth and development of the brain) disorder affecting primarily females. RS is characterized by the loss of intellectual functioning, fine and gross motor skills, and communicative abilities after a period of seemingly normal development. * Caregivers of individuals with RS face many psychosocial challenges. The stressors can be grouped into the following six categories: emotional difficulties, health-related stressors, uncertainty about their daughter s illness, rejection by their social environment, lack of available or competent experts, and unfavorable comparison with healthy children. * Researchers are making a significant contribution to the adaptation literature with a focus on family functioning and to the little psychosocial research that exists on families with RS. * Researchers hope to narrow down the most important areas on which to focus for intervention strategies in families with RS. Objectives: * To describe family functioning, perceived illness burden, self-efficacy, types of coping methods, and adaptation in caregivers of individuals with RS to examine the relationships between these variables and the outcomes of family functioning and adaptation. * To examine the extent to which appraisals of being a caregiver of an individual with RS and methods of coping are associated with family functioning. * To examine the extent to which appraisals of being a caregiver of an individual with RS, methods of coping, and family functioning are associated with caregiver adaptation. Eligibility: \- Eligibility is based on answering yes to the following three questions: Are you 18 years old or older? Are you the caregiver of a child diagnosed with Rett Syndrome? and Does the child with Rett Syndrome currently reside in your home with you? Design: * Participants in this cross-sectional research design will answer a quantitative survey that incl

Conditions Studied

Study Locations (3)

Alabama

  • University of Alabama - Birmingham

Maryland

  • Kennedy Krieger Institute - Baltimore

Texas

  • Baylor College of Medicine - Houston

Trial Details

FieldValue
Enrollment Target 426 participants
Start Date 2009-04-24
Est. Completion 2016-01-13

What the finished NCT00891956 record still lists

NCT00891956 is an observational study that tracks outcomes without assigning an intervention. The registered 426 participants enrollment target is mid-sized for trials with a published cap, below the 502-participant average among 18 other Rett Syndrome trials with a reported enrollment target (15% lower).

The record links to 1 condition, with Rett Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT00891956 reports a single indexed study location in Alabama, Maryland, Texas.

Frequently Asked Questions

What is clinical trial NCT00891956 about?

NCT00891956 is a clinical study titled "The Role of Family Functioning in Adaptation to Being a Caregiver of an Individual With Rett Syndrome". Background: * Rett syndrome (RS) is a panethnic (affecting all ethnicities) neurodevelopmental (impairment of the growth and development of the brain) disorder affecting primarily females. RS is characterized by the loss of intellectual functioning, fine and gross motor skills, and communicative ab...

What is the current status of trial NCT00891956?

This trial is currently completed. The enrollment target is 426 participants. The study started on 2009-04-24. Estimated completion is 2016-01-13.

What conditions does trial NCT00891956 study?

This clinical trial studies the following conditions: Rett Syndrome.

Who is sponsoring clinical trial NCT00891956?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00891956 being conducted?

This trial has 3 study locations across Alabama, Maryland, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rett Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00891956's enrollment target sits among peer trials

426 3rd of 18 higher than 16 of 18 other Rett Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rett Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06790784 · 426 participants · Phase 3

    Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR

  • NCT04265430 · 425 participants · Phase 4

    Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

  • NCT04278690 · 425 participants · NA

    Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

  • NCT05321368 · 425 participants · NA

    A Cardiometabolic Health Program Linked With Clinical-Community Support and Mobile Health Telemonitoring to Reduce Health Disparities

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00891956, the US trial registry maintained by the National Library of Medicine. NCT00891956 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.